Efficacy and safety of mavacamten in treatment of hypertrophic cardiomyopathy: a systematic review and meta-analysis
Aim: This meta-analysis was performed to assess the efficacy and safety of mavacamten in patients with hypertrophic cardiomyopathy. Methods & materials: A search was conducted using PubMed, Cochrane, and Scopus up to August 2022 for randomized studies reporting our pre-specified outcomes. Results: I...
保存先:
| 主要な著者: | , , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Taylor & Francis Group
2023-12-01
|
| シリーズ: | Future Science OA |
| 主題: | |
| オンライン･アクセス: | https://www.future-science.com/doi/10.2144/fsoa-2023-0059 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|